Findings

What do systematic reviews say?

9 questions · 9 findings · 2 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 8 · 88.9%Low 1 · 11.1%Moderate 0 · 0%High 0 · 0%

GnRHa treatment vs danazol

Relief of pain · patients with pain associated with endometriosis

1 finding from 1 review

Gonadotropin‐releasing hormone analogues for endometriosis 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 41 participants
Very low

GnRHa treatment vs danazol

Relief of overall pain ‐ reported as pelvic pain ‐ 3 months · patients with pain associated with endometriosis

1 finding from 1 review

Gonadotropin‐releasing hormone analogues for endometriosis 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 41 participants
Very low

GnRHa treatment vs danazol

Relief of overall pain ‐ reported as dysmenorrhoea ‐ 6 months · patients with pain associated with endometriosis

1 finding from 1 review

Gonadotropin‐releasing hormone analogues for endometriosis 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 41 participants
Very low

GnRHa treatment vs danazol

Relief of overall pain ‐ reported as pelvic induration ‐ 6 months · patients with pain associated with endometriosis

1 finding from 1 review

Gonadotropin‐releasing hormone analogues for endometriosis 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 41 participants
Very low

GnRHa treatment vs danazol

Relief of overall pain ‐ reported as pelvic tenderness ‐ 6 months · patients with pain associated with endometriosis

1 finding from 1 review

Gonadotropin‐releasing hormone analogues for endometriosis 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 41 participants
Very low

GnRHa treatment vs danazol

Relief of overall pain ‐ reported as pelvic tenderness, partly resolved ‐ 6 months · patients with pain associated with endometriosis

It is very uncertain whether gnRHas changes relief of overall pain ‐ reported as pelvic tenderness, partly… compared with danazol (very low certainty).

1 finding from 1 review

Gonadotropin‐releasing hormone analogues for endometriosis 2023 · Cochrane Headline outcomes only
RR 1.15 [0.49, 2.73]
1 study · 41 participants
Very low

GnRHa treatment vs danazol

Relief of overall pain ‐ reported as pelvic tenderness, complete resolved ‐ 6 months · patients with pain associated with endometriosis

It is very uncertain whether gnRHas changes relief of overall pain ‐ reported as pelvic tenderness, complete… compared with danazol (very low certainty).

1 finding from 1 review

Gonadotropin‐releasing hormone analogues for endometriosis 2023 · Cochrane Headline outcomes only
RR 1.1 [0.67, 1.81]
1 study · 41 participants
Very low

GnRHa treatment vs danazol

Relief of painful symptoms ‐ Dysmenorrhoea · patients with pain associated with endometriosis

It is very uncertain whether gnRHas changes relief of painful symptoms ‐ Dysmenorrhoea compared with danazol (very low certainty).

1 finding from 1 review

Gonadotrophin‐releasing hormone analogues for pain associated with endometriosis 2010 · Cochrane Headline outcomes only
RR 0.98 [0.92, 1.04]
7 studies · 666 participants
Very low

GnRHa treatment vs danazol

Overall resolution ‐ Overall resolution/improvement · patients with pain associated with endometriosis

GnRHas may leads to higher overall resolution ‐ Overall resolution/improvement compared with danazol (low certainty).

1 finding from 1 review

Gonadotrophin‐releasing hormone analogues for pain associated with endometriosis 2010 · Cochrane Headline outcomes only
RR 1.1 [1.01, 1.21]
9 studies · 1046 participants
Low